Denise Raddatz
Nurse Practitioner · Fife, WANPI 1558193219
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 91.0% of the total across 158 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 38 manufacturers, the largest accounting for just 12.0% — the pattern of someone who eats at a lot of different presentations. Among nurse practitioner clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 158 payments — averaging $24.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$454
- AstraZeneca$451
- AbbVie$395
- Novartis$205
- Pfizer$188
- Daiichi Sankyo Inc.$179
- plus $2K from 32 others
What the payments were for
- Food & beverage$3,45291%
- Education$3439%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 15 | $454 |
| AstraZeneca | 15 | $451 |
| AbbVie | 17 | $395 |
| Novartis | 9 | $205 |
| Pfizer | 13 | $188 |
| Daiichi Sankyo Inc. | 11 | $179 |
| E.r. Squibb & Sons, L.L.C. | 2 | $156 |
| Stemline Therapeutics Inc. | 8 | $139 |
| Beone Medicines USA, Inc. | 6 | $125 |
| Merck | 4 | $102 |
| Genmab U.S., Inc. | 3 | $101 |
| Tersera Therapeutics LLC | 3 | $96 |
| Array Biopharma Inc | 6 | $95 |
| Seagen Inc. | 1 | $95 |
| Menarini Silicon Biosystems, Inc. | 3 | $95 |
| Bristol Myers Squibb | 4 | $87 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $80 |
| Incyte Corporation | 3 | $70 |
| Rigel Pharmaceuticals, Inc. | 2 | $61 |
| Gilead | 3 | $60 |
| Syndax Pharmaceuticals, Inc. | 2 | $54 |
| Boehringer Ingelheim | 2 | $49 |
| Beigene USA, Inc. | 2 | $48 |
| Eisai Inc. | 3 | $48 |
| Iovance Biotherapeutics, Inc. | 2 | $47 |
| Dendreon Pharmaceuticals LLC | 2 | $44 |
| ADC Therapeutics America, Inc. | 2 | $39 |
| Blueprint Medicines Corporation | 1 | $30 |
| Taiho Oncology, Inc. | 1 | $30 |
| Progenics Pharmaceuticals, Inc. | 1 | $27 |
| Azurity Pharmaceuticals, Inc. | 1 | $23 |
| Biocon Biologics Inc | 1 | $23 |
| Puma Biotechnology, Inc. | 1 | $22 |
| Astellas Pharma US Inc | 1 | $20 |
| Pharmaessentia USA Corporation | 1 | $16 |
| Genentech USA, Inc. | 1 | $16 |
| Exelixis Inc. | 1 | $14 |
| Lilly USA, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Reblozyl$135
How this compares
$3,795 in reported general payments places this provider in the 95th percentile of 2,466 nurse practitioner providers in Washington.
Other nurse practitioner in Fife
- Olga VoloshinaSeattle$279K
- Sandra ChristensenSeattle$244K
- Felicia ForrestLynnwood$206K
- Amaris MurphyBellevue$146K
- Sonia GlennieSeattle$78K
- Megan WildesTacoma$72K
- Kate KennedyBellevue$63K
- Vicki HainesPasco$57K
- Jessica ArmitageSumner$46K
- Lia Duque Estrada de BarrosSeattle$43K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.